| 000 | 00697nam a2200229Ia 4500 | ||
|---|---|---|---|
| 003 | OSt | ||
| 005 | 20230315111002.0 | ||
| 008 | 180620b2007 xxu||||| |||| 00| 0 eng d | ||
| 020 | _a0824729455 | ||
| 040 | _cJUIT, Solan | ||
| 082 | _a615.1 HAU | ||
| 100 | _aHauss, David J. | ||
| 245 |
_aOral Lipid-Based Formulations: enhancing the bioavailability of poorly water-soluble drugs _cby David J. Hauss |
||
| 260 |
_aNew York _bInforma Healthcare _c2007 |
||
| 300 | _axii, 339p. | ||
| 365 | _a.00 | ||
| 505 | _aContents: 1. Currently marketed oral Li | ||
| 650 | _aLipids -- Therapeutic use | ||
| 650 | _aDrugs -- Solubility | ||
| 906 | _a2dbfb5407f000001012fe068840aae88 | ||
| 942 |
_2ddc _cRB |
||
| 999 |
_c15781 _d15781 |
||